Hus I - Search Results

1

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

Hus I, Roliński J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, Giannopoulos K, Dmoszyńska A, Schmitt M. Hus I, et al. Leukemia. 2005 Sep;19(9):1621-7. doi: 10.1038/sj.leu.2403860. Leukemia. 2005. PMID: 15990861 Clinical Trial.

2

[Spontaneous and induced production of tumor necrosis factor (TNF alpha) by peripheral blood leukocytes in patients with acute leukemia type M 4 and M5 according to FAB].

Dmoszyńska A, Kandefer-Szerszeń M, Borowska L, Adamczyk-Cioch MB, Hus I, Hus M, Roliński J. Dmoszyńska A, et al. Among authors: hus m, hus i. Acta Haematol Pol. 1995;26(2):205-11. Acta Haematol Pol. 1995. PMID: 7653227 Polish.

3

[Clinical and immunologic characteristics of CD 34 positive acute myeloid leukemia].

Adamczyk-Cioch MB, Dmoszyńska A, Hus M, Hus I. Adamczyk-Cioch MB, et al. Among authors: hus m, hus i. Pol Arch Med Wewn. 1995 Jul;94(1):40-6. Pol Arch Med Wewn. 1995. PMID: 8524698 Polish.

4

Interferon production by peripheral blood leukocytes of patients with acute myeloid leukemia.

Kandefer-Szerszeń M, Dmoszyńska A, Borowska L, Adamczyk-Cioch M, Hus M, Hus I, Roliński J. Kandefer-Szerszeń M, et al. Among authors: hus m, hus i. Arch Immunol Ther Exp (Warsz). 1996;44(2-3):119-22. Arch Immunol Ther Exp (Warsz). 1996. PMID: 8915515

5

Interferon gamma as immunomodulator in a patient with multiple myeloma.

Kamińska T, Dmoszyńska A, Cioch M, Hus I, Jawniak D, Szuster-Ciesielska A, Kandefer-Szerszeń M. Kamińska T, et al. Among authors: hus i. Arch Immunol Ther Exp (Warsz). 1999;47(2):107-12. Arch Immunol Ther Exp (Warsz). 1999. PMID: 10202563

6

Cytokine production in whole blood cell cultures of patients with B-lineage acute lymphoblastic leukemia. The influence of granulocyte-macrophage colony-stimulating factor.

Kamińska T, Hus I, Dmoszyńska A, Kandefer-Szerszeń M. Kamińska T, et al. Among authors: hus i. Arch Immunol Ther Exp (Warsz). 2001;49(1):71-7. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11266094

7

Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia.

Kamińska T, Hus I, Dmoszyńska A, Kandefer-Szerszeń M. Kamińska T, et al. Among authors: hus i. Arch Immunol Ther Exp (Warsz). 2001;49 Suppl 2:S83-7. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11665752

8

Effect of granulocyte colony stimulating factor treatment on ex vivo cytokine production by blood cells of patients after chemotherapy or radiotherapy.

Kamińska T, Dmoszyńska A, Hus I, Croneck AW, Kandefer-Szerszeń M. Kamińska T, et al. Among authors: hus i. Arch Immunol Ther Exp (Warsz). 1999;47(1):61-5. Arch Immunol Ther Exp (Warsz). 1999. PMID: 11729831

9

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma.

Hus I, Dmoszynska A, Manko J, Hus M, Jawniak D, Soroka-Wojtaszko M, Hellmann A, Ciepluch H, Skotnicki A, Wolska-Smolen T, Sulek K, Robak T, Konopka L, Kloczko J. Hus I, et al. Among authors: hus m. Br J Cancer. 2004 Nov 29;91(11):1873-9. doi: 10.1038/sj.bjc.6602225. Br J Cancer. 2004. PMID: 15520820 Free PMC article.

10

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma.

Hus M, Dmoszyńska A, Kocki J, Hus I, Jawniak D, Adamczyk-Cioch M, Grzasko N. Hus M, et al. Among authors: hus i. Leukemia. 2005 Aug;19(8):1497-9. doi: 10.1038/sj.leu.2403811. Leukemia. 2005. PMID: 15920492 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters